Grab insights on development paths for spine therapy innovation including preclinical testing in the $15 billion global market. Connect onsite with T3 Labs at NASS 2016.

Share

According to Markets and Markets Research, the global market for spinal implants and devices will top $15 billion by 2020. In North America, the gathering with arguably the greatest ability to influence that market, its innovation and growth is the North American Spine Society (NASS) Annual Meeting.

T3 Labs’ Orthopaedic and Spine Program Director Dr. Evan Goldberg, a five-time veteran of the industry leading spine conference, will be onsite at NASS 2016 in Boston October 26-29.

“Catching up with our preclinical testing sponsors and learning about their latest developments and products in the pipeline is a highlight of NASS for me,” Evan said. “It is the place to learn about the latest trends in the field including new devices, biologics and surgical techniques. All of the clinicians, all of the big players and hundreds of innovators evaluating their readiness for a preclinical journey for their orthopedic medical devices are there.”
What you need when you need it in preclinical testing and training for orthopaedic and spine
T3 Labs is an industry leading preclinical CRO that provides what you need when you need it for our orthopaedic and spine sponsors in their journeys from proof of concept to first-in-man for their innovative therapies.

“For a sponsor in an orthopedic trauma model, we are nearing full circle product development, from concept-to-cure. We have helped them navigate the orthopaedic device innovation process from proof-of-concept through their regulatory filings. We believe this sponsor will achieve a ‘first-in-man’ status with a game-changing orthopedic product in the next 6 months. This is precisely what we hope for as an organization, as scientists ourselves and as stewards of our sponsors’ investments in preclinical medical device testing and training.”

T3 Labs’ relationships with the Emory Orthopedics and Spine Center, the Georgia Institute of Technology Petit Institute for Bioengineering and Bioscience and GCMI (the Global Center for Medical Innovation) bring deep knowledge and create seamless simplicity and economy for orthopedic and spine innovators via one preclinical CRO engagement.

“T3 Labs’ prowess for preclinical research including its surgical suite, animal husbandry infrastructure, experimental expertise and microCT imaging capabilities is outstanding. I feel that T3 Labs’ preclinical imaging like microCT, supplemented by quantitative software-driven image analysis provided by ImageIQ, is a high-value investment capable of accelerating the time-to-market for medical devices and biologics.” – Brett Hoover, Vice President, ImageIQ

Related: Can advanced medical imaging like microCT accelerate preclinical trials?

From concept to commercialization, T3 completes the circle with proven medical device training programs

Once your product is on the market, we can help you come full circle with our physician and sales force training programs. Whether your product has just been or is about to be approved or you are at the very early stage of device development seeking your customer feedback, T3 Labs can help you translate rapidly between device testing and regulatory approval ultimately helping you convert sales.

Connect with T3 Labs at NASS 2016
To learn more about T3 Labs’ capabilities in preclinical medical device testing and training, connect with Evan Goldberg onsite at NASS 2016 October 26 – 29 via email: evan.j.goldberg@emoryhealthcare.org.

Follow T3 Labs on LinkedIn and Twitter as well!